INTEGRIUM
DEAD

Serial Number

76476020

Owner

Integrium, LLC

Attorney

James L. Bikoff

First Use Date

Aug 15, 2002

Filing Date

Dec 16, 2002

Add to watchlist:

No watchlists yet
View on USPTO

INTEGRIUM Trademark

Serial Number: 76476020 • Registration: 2822550

INTEGRIUM is a trademark filed by Integrium, LLC on December 16, 2002. The trademark is classified under Class 37 (Building & Construction), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Integrium, LLC (8 trademarks)

14351 Myford Road
Tustin, CA 92780

Entity Type: 16

Trademark Details

Filing Date

December 16, 2002

Registration Date

March 16, 2004

First Use Anywhere

August 15, 2002

First Use in Commerce

August 15, 2002

Published for Opposition

December 23, 2003

Cancellation Date

October 22, 2010

Goods & Services

TRAINING CLINICAL TRIAL SITE PERSONNEL CONCERNING DRUG PROTOCOL REQUIREMENTS AND THE USE OF TESTS AND RATING SYSTEMS FOR SUCH PROTOCOL; TRAINING CLINICAL TRIAL PERSONNEL IN THE USE OF MEDICAL AND RESEARCH EQUIPMENT REQUIRED BY DRUG AND/OR DEVICE PROTOCOLS; ARRANGING MEDICAL CONFERENCES AND SYMPOSIA; PROVIDING CONTINUING MEDICAL EDUCATION TO PHYSICIANS AND OTHER HEALTH-CARE PROVIDERS AND ARRANGING AND MANAGING SPEAKERS' BUREAUS IN CONJUNCTION THEREWITH; MEDICAL MANUSCRIPT PREPARATION AND SUBMISSION; DEVELOPMENT AND PUBLICATION OF MEDICAL JOURNALS

REAL ESTATE SITE SELECTION, NAMELY, INSPECTING BUILDINGS AND OFFICES AS POTENTIAL SITES FOR HOSTING CLINICAL TRIALS

MANAGEMENT ASSISTANCE FOR CLINICAL TRIALS OF INVESTIGATIONAL DRUGS, NAMELY, ARRANGING FOR SITES TO PERFORM CLINICAL TRIALS, ARRANGING FOR THE IMPORT, PACKAGING, SHIPPING, LABELING, AND DISTRIBUTION OF DRUGS AND OTHER INVESTIGATIONAL SUPPLIES AND EQUIPMENT TO AND FROM THE CLINICAL TRIAL SITES, ARRANGING FOR THE CENTRAL COLLECTION OF LABORATORY SPECIMENS FROM CLINICAL TRIAL SITES, MAKING ANY AND ALL FILINGS REQUIRED BY THE FOOD AND DRUG ADMINISTRATION FOR INVESTIGATIONAL NEW DRUGS AND NEW DRUG APPLICATIONS, PREPARING STATISTICAL REPORTS RESULTING FROM CLINICAL TRIALS; COOPERATIVE ADVERTISING AND MARKETING OF NEW DRUGS

PROVIDING MEDICAL MONITORING SERVICES, NAMELY REVIEW OF TRIAL DATA REPORTS FOR SAFETY PURPOSES, AND TO DETERMINE AND ASSURE COMPLIANCE WITH CLINICAL STUDY PROTOCOL REQUIREMENTS AS WELL AS COMPLIANCE WITH GOOD CLINICAL PRACTICES AND FOOD AND DRUG ADMINISTRATION AND/OR OTHER REGULATIONS GOVERNING CLINICAL TRIALS

TECHNICAL WRITING OF CLINICAL TRIAL REPORTS FOR OTHERS; DATABASE DEVELOPMENT SERVICES TO PROCESS DATA COLLECTED FROM CLINICAL TRIALS; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 22, 2010 C8..
REGISTERED-PRINCIPAL REGISTER
Mar 16, 2004 R.PR
PUBLISHED FOR OPPOSITION
Dec 23, 2003 PUBO
NOTICE OF PUBLICATION
Dec 3, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 22, 2003 CNSA
CASE FILE IN TICRS
Aug 22, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2003 CRFA
PAPER RECEIVED
Aug 4, 2003 MAIL
NON-FINAL ACTION MAILED
Apr 2, 2003 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2003 DOCK